Open AccessTirzepatide — a dual GIP/GLP-1 receptor agonist — a new antidiabetic drug with potential metabolic activity in the treatment of type 2 diabetes
Author(s) -
Mariusz Nowak,
Wojciech Nowak,
W Grzeszczak
Publication year - 2022
Publication title -
endokrynologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.413
H-Index - 27
eISSN - 2299-8306
pISSN - 0423-104X
DOI - 10.5603/ep.a2022.0029
Subject(s) - incretin , medicine , postprandial , type 2 diabetes mellitus , endocrinology , type 2 diabetes , drug , agonist , pharmacology , insulin , gastric inhibitory polypeptide , diabetes mellitus , receptor , glucagon